Work

Presurgical evaluation of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.2613

Authors: Kevin Kalinsky, Joseph A. Sparano, Eleni Andreopoulou, Bret Taback, Lisa Silvia Wiechmann, Sheldon M. Feldman, Preya Ananthakrishnan, Hanina Hibshoosh, John Manavalan, Katherine D. Crew, Matthew A. Maurer, Dawn L. Hershman

Institutions: Columbia University Irving Medical Center, Montefiore Medical Center, Albert Einstein College of Medicine, Columbia University

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4251492013

Cites:

Cited by: 6

Related to: 10